CLINICAL_TRIALS trial_result · 2021-01-22

Clinical Trial Update: A Randomized Study to Evaluate the Efficacy of Insulclock® in Patients With Uncontrolled Type 2 Diabetes [NA]

A randomized trial evaluating Insulclock® for uncontrolled type 2 diabetes has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Emory University | Conditions: Diabetes | NA | Status: COMPLETED | Results posted: 2021-01-22